UT Health Science Center-San Antonio: A New Era In Alzheimer's Treatment
January 12, 2023
January 12, 2023
SAN ANTONIO, Texas, Jan. 12 (TNStalk) -- The University of Texas Health Science Center at San Antonio issued the following statement on Jan. 11, 2023:
* * *
Statement from the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news:
The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer's dis . . .
* * *
Statement from the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news:
The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer's dis . . .